Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe SARS-CoV2 Pneumonia”

Showing 20 of 0 results

Not applicableWithdrawnNCT04298814
What this trial is testing

Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia

Who this might be right for
COVID-19Endotracheal Intubation
Tongji Hospital
Large-scale testing (Phase 3)UnknownNCT05689008
What this trial is testing

UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia

Who this might be right for
Mesenchymal Stem CellCOVID-19 Pneumonia
Shanghai East Hospital 60
Not applicableStudy completedNCT05263908
What this trial is testing

Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Pfizer 3,346
Large-scale testing (Phase 3)UnknownNCT04656613
What this trial is testing

A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE

Who this might be right for
Covid19SARS-CoV Infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 1,000
Not applicableStudy completedNCT04644159
What this trial is testing

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]

Who this might be right for
SARS (Severe Acute Respiratory Syndrome)Covid19
Institut Pasteur 1,000
Testing effectiveness (Phase 2)Study completedNCT04808882
What this trial is testing

ANTIcoagulation in Severe COVID-19 Patients

Who this might be right for
Severe COVID-19 Pneumonia
Assistance Publique - Hôpitaux de Paris 353
Early research (Phase 1)Study completedNCT04482686
What this trial is testing

Trial of Combination Therapy to Treat COVID-19 Infection

Who this might be right for
COVIDCovid-19Corona Virus Infection+4 more
ProgenaBiome 31
Not applicableNo Longer AvailableNCT04355494
What this trial is testing

SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19

Who this might be right for
COVID-19Pneumonia, ViralAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Alexion Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT05890612
What this trial is testing

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

Who this might be right for
COVID-19
Pfizer 3,000
Not applicableNo Longer AvailableNCT04646031
What this trial is testing

Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19

Who this might be right for
Covid19
Tasly Pharmaceuticals, Inc.
Not applicableStudy completedNCT04349202
What this trial is testing

Beaumont Health Large-scale Automated Serologic Testing for COVID-19

Who this might be right for
COVID-19Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2
Corewell Health East 20,614
Not applicableLooking for participantsNCT05835102
What this trial is testing

Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection

Who this might be right for
COVID-19
Juan Kang 800
Not applicableLooking for participantsNCT07781501
What this trial is testing

Long-Term Study of COVID-19 Infection and Long COVID

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
University of North Carolina, Chapel Hill 500
Large-scale testing (Phase 3)Looking for participantsNCT05261139
What this trial is testing

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Who this might be right for
COVID-19
Pfizer 160
Testing effectiveness (Phase 2)Ended earlyNCT04447235
What this trial is testing

Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

Who this might be right for
CancerCOVIDCoronavirus Infection
Instituto do Cancer do Estado de São Paulo 77
Not applicableStudy completedNCT04491214
What this trial is testing

Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)

Who this might be right for
Covid19Follow upRehabilitation
University Hospital, Strasbourg, France 112
Not applicableStudy completedNCT04446429
What this trial is testing

Anti-Androgen Treatment for COVID-19

Who this might be right for
COVID-19SARS-CoV2Androgenetic Alopecia+3 more
Applied Biology, Inc. 268
Not applicableStudy completedNCT04546776
What this trial is testing

COVID-19 Persistence in Stool

Who this might be right for
SARS-CoV Infection
Quadram Institute Bioscience 105
Large-scale testing (Phase 3)Study completedNCT04878055
What this trial is testing

Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.

Who this might be right for
Pneumonia, Viral
Dompé Farmaceutici S.p.A 287
Not applicableStudy completedNCT04958889
What this trial is testing

COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)HIV
Johns Hopkins University 392
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation